CDT Equity Inc. (CDT)
Nasdaq: CDT · Pharmaceutical Preparations · Naples, FL · filing with the SEC since 2021
Who owns CDT Equity Inc.
As filed with the SECHolders of 5% or more
2
Andrew Regan holds 22.1% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Oct 27, 2026 says.
Directors and officers
6
report now, of 14 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Andrew Regan
SCHEDULE 13D/A · filed Oct 27, 2026 · Common Stock, par value $0.0001 per share · 43.7% in Sep 2, 2026
A.G.P. / Alliance Global Partners, LLC
SCHEDULE 13G · filed May 15, 2025 · Common Stock, par value $0.0001 per share
Ascent Partners Fund LLC
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.9% in Jun 5, 2026
Sarborg Ltd
SCHEDULE 13G/A · filed Aug 18, 2025 · Common Stock · reported falling below 5%, from 16.4% in May 7, 2025
Primary Development Fund (Cayman) SPC
SCHEDULE 13G/A · filed Oct 8, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.2% in Oct 7, 2026
Taylor Mark Andrew
SCHEDULE 13G/A · filed Oct 7, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.6% in Sep 2, 2026
Wigglesworth Craig Stuart
SCHEDULE 13G/A · filed Oct 7, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.6% in Sep 9, 2026
Nirland Limited
SCHEDULE 13G · filed May 20, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 0% in Feb 20, 2025
AstraZeneca PLC
SCHEDULE 13G/A · filed Apr 10, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
What CDT reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Alliance Global Partners
An entity · legal entity · owns, named in the 10-K filed Apr 15, 2026
Astra Zeneca
An entity · legal entity · owns, named in the 10-K filed Apr 15, 2026
Nirland Limited
An entity · legal entity · owns, named in the 10-K filed Apr 15, 2026
Murphy Canyon Acquisition Corp
A company bought · acquisition · owns, named in the 10-K filed Apr 15, 2026
Insider tradesForm 4
2sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 27, 2025 to Oct 27, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Oct 27, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Prospect Capital Securities Ltd | 10% owner | 4 | $2.9M | 0 | 0 | $0 |
| Regan Andrew | Chief Executive Officer | 2 | $0 | 0 | 0 | $0 |